Veterinary Medicines

Surcalce - Injektionslösung für Pferd, Rind, Schwein, Schaf, Ziege

Authorised
  • Calcium gluconate monohydrate
  • Calcium acetate
  • Magnesium hypophosphite hexahydrate
Download as PDF

Product identification

Medicine name:
Surcalce - Injektionslösung für Pferd, Rind, Schwein, Schaf, Ziege
Active substance:
  • Calcium gluconate monohydrate
  • Calcium acetate
  • Magnesium hypophosphite hexahydrate
Target species:
  • Cattle
  • Goat
  • Sheep
  • Horse
  • Pig
  • Pig (piglet)
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Calcium gluconate monohydrate
    465.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium acetate
    37.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium hypophosphite hexahydrate
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Pig
      • Meat and offal
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AA20
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Sanochemia Pharmazeutika AG
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 16368
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/07/2020
Updated on: 5/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/07/2020
Updated on: 5/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/07/2020
Updated on: 5/08/2025
Download